NYSE ARCA | ETF
The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing inU. S.-listed equity securities, selected based on the adviser"s assessment of a company"s valuation, cash flow stability, and balance sheet quality ("fundamental factors").
Under normal circumstances, at least 80% of its net assets, plus borrowings for investment purposes, will be invested inU. S. assets.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 3.41% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 2.53% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 2.47% |
| GOOGL | Alphabet Inc Class A | Communication Services | Internet Content & Information | 2.33% |
| AVGO | Broadcom Inc | Technology | Semiconductors | 2.30% |
| TMUS | T-Mobile US Inc | Communication Services | Telecom Services | 2.15% |
| CRM | Salesforce.com Inc | Technology | Software - Application | 2.10% |
| V | Visa Inc. Class A | Financial Services | Credit Services | 2.00% |
| CSCO | Cisco Systems Inc | Technology | Communication Equipment | 1.91% |
| PG | Procter & Gamble Company | Consumer Defensive | Household & Personal Products | 1.87% |
| CMCSA | Comcast Corp | Communication Services | Telecom Services | 1.75% |
| PM | Philip Morris International Inc | Consumer Defensive | Tobacco | 1.73% |
| QCOM | Qualcomm Incorporated | Technology | Semiconductors | 1.63% |
| CI | Cigna Corp | Healthcare | Healthcare Plans | 1.60% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.47% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 1.47% |
| AMAT | Applied Materials Inc | Technology | Semiconductor Equipment & Materials | 1.46% |
| 1BLK | BlackRock, Inc. | Financial Services | Asset Management | 1.44% |
| ELV | Elevance Health Inc | Healthcare | Healthcare Plans | 1.43% |
| HON | Honeywell International Inc | Industrials | Conglomerates | 1.40% |